Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: A prospective clinical trial

BMC Medicine

Volumn 8, Issue , 2010, Pages

  Nakagawa, Takayuki ^a   Sakamoto, Tatsunori ^a   Hiraumi, Harukazu ^a   Kikkawa, Yayoi S ^a,b   Yamamoto, Norio ^a   Hamaguchi, Kiyomi ^a   Ono, Kazuya ^a,c   Yamamoto, Masaya ^d   Tabata, Yasuhiko ^d   Teramukai, Satoshi ^e   Tanaka, Shiro ^e   Tada, Harue ^e   Onodera, Rie ^f   Yonezawa, Atsushi ^e   Inui, Ken Ichi ^e   Ito, Juichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

^f SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; SOMATOMEDIN C; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EXTERNAL OTITIS; FEMALE; HUMAN; HYDROGEL; HYPERBARIC OXYGEN; MALE; MIDDLE EAR; NAUSEA; OTITIS MEDIA; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; SUDDEN SENSORINEURAL HEARING LOSS; TREATMENT OUTCOME; TREATMENT RESPONSE; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; FEMALE; GLUCOCORTICOIDS; HEARING LOSS, SENSORINEURAL; HUMANS; HYDROGELS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 78649317830     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-76     Document Type: Article

References (26)

1. National Institute of Health Sudden Deafness 2000, NIH publication 00-4757. Bethesda, MD: National Institutes of Health, National Institute of Health.
2. Teranishi M, Katayama N, Uchida Y, Tominaga M, Nakashima T. Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan. Acta Oto-Laryngologica 2007, 127:1259-1265. 10.1080/00016480701242410, 17851966.
3. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 1980, 106:772-776.
4. Roberson DW, Rubel EW. Cell division in the gerbil cochlea after acoustic trauma. Am J Otol 1994, 15:28-34.
5. Malgrange B, Rigo JM, Van de Water TR, Staecker H, Moonen G, Lefebvre PP. Growth factor therapy to the damaged inner ear: clinical prospects. Int J Pediatr Otorhinolaryngol 1999, 49(Suppl 1):S19-25. 10.1016/S0165-5876(99)00126-3, 10577769.
6. Romand R, Chardin S. Effects of growth factors on the hair cells after ototoxic treatment of the neonatal mammalian cochlea in vitro. Brain Res 1999, 825:46-58. 10.1016/S0006-8993(99)01211-1, 10216172.
7. Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim TS, Tabata Y, Ito J. Cochlear protection by local IGF-1 application using biodegradable hydrogel. Laryngoscope 2006, 116:526-533.
8. Inaoka T, Nakagawa T, Kikkawa YS, Tabata Y, Ono K, Yoshida M, Tsubouchi H, Ido A, Ito J. Local application of hepatocyte growth factor using gelatin hydrogels attenuates noise-induced hearing loss in guinea pigs. Acta Otolaryngol 2009, 129:453-457. 10.1080/00016480902725197, 19214837.
9. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J. A novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005, 115:2016-2020. 10.1097/01.mlg.0000183020.32435.59, 16319616.
10. Young S, Wong M, Tabata Y, Mikos AG. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005, 109:256-274. 10.1016/j.jconrel.2005.09.023, 16266768.
11. Lee KY, Nakagawa T, Okano T, Hori R, Ono K, Tabata Y, Lee SH, Ito J. Novel therapy for hearing loss: delivery of insulin-like growth factor-1 to the cochlea using gelatin hydrogel. Otol Neurotol 2007, 28:976-981. 10.1097/MAO.0b013e31811f40db, 17704706.
12. Fujiwara T, Hato N, Nakagawa T, Tabata Y, Yoshida T, Komobuchi H, Takeda S, Hyodo J, Hakuba N, Gyo K. IGF1 treatment via hydrogels rescues cochlear hair cells from ischemic injury. Neuroreport 2008, 19:1585-1588. 10.1097/WNR.0b013e328311ca4b, 18845939.
13. Kanzaki J, Inoue Y, Ogawa K, Fukuda S, Fukushima K, Gyo K, Yanagihara N, Hoshino T, Ishitoya J, Toriyama M, Kitamura K, Murai K, Nakashima T, Niwa H, Nomura Y, Kobayashi H, Oda M, Okamoto M, Shitara T, Sakagami M, Tono T, Usami S. Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 2003, 30:123-127. 10.1016/S0385-8146(03)00009-9, 12753981.
14. Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, Saji Y, Inui K, Hashida T, Yokoyama S, Onodera R, Ikeda T, Fukushima M, Komeda M. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 2007, 71:1181-1186. 10.1253/circj.71.1181, 17652878.
15. Miura M, Sakamoto T, Hiraumi H, Kanemaru S, Ito J. Evaluation of hyperbaric oxygen therapy for the treatment of sudden hearing loss in both primary and secondary cases. Practica Oto-Rhino-Laryngologica 2008, 101:749-757.
16. Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: evidence from Taiwan. Audiol Neurootol 2006, 11:151-156. 10.1159/000091198, 16449805.
17. Nosrati-Zarenoe R, Arlinger S, Hultcrantz E. Idiopathic sudden sensorineural hearing loss: results drawn from the Swedish national database. Acta Otolaryngol 2007, 127:1168-1175. 10.1080/00016480701242477, 17851927.
18. Castro NP, Almeida CI, Campos CA. Sudden sensorineural hearing loss and vertigo associated with arterial occlusive disease: three case reports and literature review. Sao Paulo Med J 2007, 125:191-195.
19. Ragab A, Shreef E, Behiry E, Zalat S, Noaman M. Randomised, double-blinded, placebo-controlled, clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss. J Laryngol Otol 2009, 123:54-60. 10.1017/S0022215108003770, 18925995.
20. Muzzi E, Zennaro B, Visentin R, Soldano F, Sacilotto C. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol 2010, 124:e2. 10.1017/S0022215109992052, 19943989.
21. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977, 86:463-480.
22. Guyot JP, Thielen K. Evolution of sudden deafness without treatment. Schweizerische Medizinische Wochenschrift 2000, 116:93S-96S.
23. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999, 109:1-17. 10.1097/00005537-199907001-00001, 10399889.
24. Free RH, Smale ND, De Kleine E, Van Der Laan BFAM. Side effects of oral dexamethasone pulse therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol 2009, 30:691. 10.1097/MAO.0b013e3181ab3380, 19503011.
25. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007, 117:3-15. 10.1097/01.mlg.0000245058.11866.15, 17202923.
26. Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol 2003, 24:728-733. 10.1097/00129492-200309000-00006, 14501447.